Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review
V Montalvan, J Lee, T Bueso, J De Toledo, K Rivas, V Montalvan, J Lee, T Bueso, J De Toledo, K Rivas
Abstract
Background: Increasing research reports neurological manifestations of COVID-19 patients. SARS-CoV-2 shares homology with other human coronaviruses that have also had nervous system involvement.
Objective: To review the neurological aspects of SARS-cov2 and other coronavirus, including transmission pathways, mechanisms of invasion into the nervous system, and mechanisms of neurological disease.
Methods: We conducted a systematic review of articles in PubMed, SCOPUS and EMBASE data bases. Reviewed evidence is presented in sections of this manuscript which includes pathogenesis, neuro-invasion, encephalitis, Guillain-Barré, ADEM, multiple sclerosis, polyneuropathy, and cerebrovascular disease.
Results: A total 67 studies were included in the final analysis of experimental studies, case reports, series of cases, cohort studies, and systematic reviews related to neurological manifestations of SARS- CoV-2 and other human coronavirus infections. The SARS-CoV-2 receptor is expressed in the nervous system. Common reported symptoms included hyposmia, headaches, weakness, altered consciousness. Encephalitis, demyelination, neuropathy, and stroke have been associated with COVID-19. Infection through the cribriform plate and olfactory bulb and dissemination through trans-synaptic transfer are some of the mechanisms proposed. Invasion of the medullary cardiorespiratory center by SARS-CoV-2 may contribute to the refractory respiratory failure observed in critically-ill COVID-19 patients.
Conclusion: An increasing number of reports of COVID-19 patients with neurological disorders add to emergent experimental models with neuro-invasion as a reasonable concern that SARS-CoV-2 is a new neuropathogen. How it may cause acute and chronic neurologic disorders needs to be clarified in future research.
Keywords: COVID-19; Coronavirus; Encephalitis; Neurological manifestations; SARS-CoV-2.
Copyright © 2020 Elsevier B.V. All rights reserved.
Figures
References
- Cucinotta D., Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157–160.
- Velavan T.P., Meyer C.G. The COVID-19 epidemic. Trop. Med. Int. Health. 2020;25(3):278–280.
- Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 2020
- Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 2020
- Wang D. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020
- Mao L. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020
- Baig A.M. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020;11(7):995–998.
- Netland J. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 2008;82(15):7264–7275.
- Ding Y. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 2004;203(2):622–630.
- Li K. Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J. Infect. Dis. 2016;213(5):712–722.
- Walls A.C. Structure, function, and Antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020
- Rothan H.A., Byrareddy S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun. 2020:102433.
- Wan Y. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 2020;94(7):e00127–20.
- Doobay M.F. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;292(1):R373–81.
- Palasca O. 2018. TISSUES 2.0: An Integrative Web Resource on Mammalian Tissue Expression. Database (Oxford) 2018.
- McCray P.B., Jr. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 2007;81(2):813–821.
- Huang C. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
- Chen N. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513.
- Xu X.W. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606.
- Sun N. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology. 1995;213(2):482–493.
- Houtman J.J., Hinze H.C., Fleming J.O. Demyelination induced by murine coronavirus JHM infection of congenitally immunodeficient mice. In: Talbot P.J., Levy G.A., editors. Corona- and Related Viruses: Current Concepts in Molecular Biology and Pathogenesis. Springer US; Boston, MA: 1995. pp. 159–163.
- Wege H. Immunopathological aspects of coronavirus infections. Semin. Immunopathol. 1995;17(2–3):133–148.
- Arbour N. Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J. Virol. 1999;73(4):3326–3337.
- Duffy L., O’Reilly S.C. Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments. Immunotargets Ther. 2016;5:69–80.
- Arbour N. Neuroinvasion by human respiratory coronaviruses. J. Virol. 2000;74(19):8913–8921.
- Murray R.S. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann. Neurol. 1992;31(5):525–533.
- Stewart J.N., Mounir S., Talbot P.J. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology. 1992;191(1):502–505.
- Gerna G. Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients. J. Clin. Virol. 2007;38(3):244–250.
- Libbey J.E., Lane T.E., Fujinami R.S. Axonal pathology and demyelination in viral models of multiple sclerosis. Discov. Med. 2014;18(97):79–89.
- Boucher A. Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients. Clin. Immunol. 2007;123(3):258–267.
- Wu G.F., Perlman S. Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J. Virol. 1999;73(10):8771–8780.
- Savarin C. Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis. J. Virol. 2008;82(24):12432–12440.
- Fehr A.R., Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol. Biol. 2015;1282:1–23.
- Yeh E.A. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics. 2004;113(1 Pt 1):e73–6.
- Algahtani H., Subahi A., Shirah B. Neurological complications of middle east respiratory syndrome coronavirus: a report of two cases and review of the literature. Case Rep. Neurol. Med. 2016;2016:3502683.
- Kim J.E. Neurological complications during treatment of middle east respiratory syndrome. J. Clin. Neurol. 2017;13(3):227–233.
- Tsai L.K., Hsieh S.T., Chang Y.C. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol. Taiwan. 2005;14(3):113–119.
- Tsai L.K. Neuromuscular disorders in severe acute respiratory syndrome. Arch. Neurol. 2004;61(11):1669–1673.
- Camdessanche J.P. COVID-19 may induce Guillain-Barre syndrome. Rev Neurol (Paris) 2020
- Turgay C. A rare cause of acute flaccid paralysis: human coronaviruses. J. Pediatr. Neurosci. 2015;10(3):280–281.
- Sedaghat Z., Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J. Clin. Neurosci. 2020
- El Otmani H. Covid-19 and Guillain-Barre syndrome: more than a coincidence! Rev Neurol (Paris) 2020
- Zhao H. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383–384.
- Toscano G. Guillain-barre syndrome associated with SARS-CoV-2. N. Engl. J. Med. 2020
- Padroni M. Guillain-Barre syndrome following COVID-19: new infection, old complication? J. Neurol. 2020
- Alberti P. Guillain-Barre syndrome related to COVID-19 infection. Neurol. Neuroimmunol. Neuroinflamm. 2020;7(4)
- Virani A. Guillain-Barre Syndrome associated with SARS-CoV-2 infection. IDCases. 2020:e00771.
- Jacomy H. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology. 2006;349(2):335–346.
- Morfopoulou S. Human coronavirus OC43 associated with fatal encephalitis. N. Engl. J. Med. 2016;375(5):497–498.
- Poyiadji N. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020:201187.
- Moriguchi T. A first case of Meningitis/Encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020
- Umapathi T. Large artery ischaemic stroke in severe acute respiratory syndrome (SARS) J. Neurol. 2004;251(10):1227–1231.
- Lew T.W. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290(3):374–380.
- Avula A. COVID-19 presenting as stroke. Brain Behav. Immun. 2020
- Guo J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme Inhibitors/Angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J. Am. Heart Assoc. 2020;9(7):e016219.
- Panigada M. Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. 2020
- Yang J. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int. J. Infect. Dis. 2020
- Zhou F. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
- Oxley T.J. Large-vessel stroke as a presenting feature of Covid-19 in the young. N. Engl. J. Med. 2020:e60.
- Powers W.J. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–e418.
- Stainsby B., Howitt S., Porr J. Neuromusculoskeletal disorders following SARS: a case series. J. Can. Chiropr. Assoc. 2011;55(1):32–39.
- Lau K.K. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis. 2004;10(2):342–344.
- Arabi Y.M. Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV) Infection. 2015;43(4):495–501.
- Lachance C. Involvement of aminopeptidase N (CD13) in infection of human neural cells by human coronavirus 229E. J. Virol. 1998;72(8):6511–6519.
- Niu J. Non-invasive bioluminescence imaging of HCoV-OC43 infection and therapy in the central nervous system of live mice. Antiviral Res. 2020;173:104646.
- Nilsson A. Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child. Infect Dis (Lond) 2020:1–4.
- Dube M. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J. Virol. 2018;92(17)
- Xu J. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin. Infect. Dis. 2005;41(8):1089–1096.
- Gu J. Multiple organ infection and the pathogenesis of SARS. J. Exp. Med. 2005;202(3):415–424.
- Alsaad K.O. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study. Histopathology. 2018;72(3):516–524.
Source: PubMed